Caroline Petitdemange
Overview
Explore the profile of Caroline Petitdemange including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
789
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Orta-Resendiz A, Petitdemange C, Schmutz S, Jacquelin B, Novault S, Huot N, et al.
STAR Protoc
. 2023 Nov;
4(4):102734.
PMID: 38032799
Here, we present a protocol for setting three spectral flow cytometry panels for the characterization of human unconventional CD8NKG2A/C T cells as well as other T and natural killer cell...
2.
Huot N, Planchais C, Rosenbaum P, Contreras V, Jacquelin B, Petitdemange C, et al.
Nat Immunol
. 2023 Nov;
24(12):2068-2079.
PMID: 37919524
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA generally becomes undetectable in upper airways after a few days or weeks postinfection. Here we used a model of viral infection in...
3.
Huot N, Planchais C, Contreras V, Jacquelin B, Petitdemange C, Lazzerini M, et al.
Res Sq
. 2022 May;
PMID: 35547853
Natural killer (NK) cells are innate lymphocytes with potent activity against a wide range of viruses. In SARS-CoV-2 infection, NK cell activity might be of particular importance within lung tissues....
4.
Petitdemange C, Funderburg N, Zaunders J, Corbeau P
Front Immunol
. 2021 Dec;
12:740556.
PMID: 34956176
No abstract available.
5.
Nzounza P, Martin G, Dereuddre-Bosquet N, Najburg V, Gosse L, Ruffie C, et al.
NPJ Vaccines
. 2021 Oct;
6(1):123.
PMID: 34686669
Replicative vectors derived from live-attenuated measles virus (MV) carrying additional non-measles vaccine antigens have long demonstrated safety and immunogenicity in humans despite pre-existing immunity to measles. Here, we report the...
6.
Rascle P, Jacquelin B, Petitdemange C, Contreras V, Planchais C, Lazzerini M, et al.
iScience
. 2021 Oct;
24(10):103109.
PMID: 34622162
B cell follicles (BCFs) in lymph nodes (LNs) are generally exempt of CD8 T and NK cells. African green monkeys (AGMs), a natural host of simian immunodeficiency virus (SIV), display...
7.
Terrade G, Huot N, Petitdemange C, Lazzerini M, Orta Resendiz A, Jacquelin B, et al.
Vaccines (Basel)
. 2021 Sep;
9(9).
PMID: 34579195
Non-human primate (NHP) models are important for vaccine development and also contribute to HIV cure research. Although none of the animal models are perfect, NHPs enable the exploration of important...
8.
Huot N, Rascle P, Petitdemange C, Contreras V, Sturzel C, Baquero E, et al.
Nat Commun
. 2021 Feb;
12(1):1282.
PMID: 33627642
Natural killer (NK) cells play a critical understudied role during HIV infection in tissues. In a natural host of SIV, the African green monkey (AGM), NK cells mediate a strong...
9.
Huot N, Rascle P, Petitdemange C, Contreras V, Palgen J, Stahl-Hennig C, et al.
Front Immunol
. 2020 Oct;
11:2134.
PMID: 33013901
Natural killer (NK) cells play essential roles in immunity to viruses and tumors. Their function is genetically determined but also modulated by environmental factors. The distribution and functional regulation of...
10.
Arunachalam P, Charles T, Joag V, Bollimpelli V, Scott M, Wimmers F, et al.
Nat Med
. 2020 May;
26(6):932-940.
PMID: 32393800
Recent efforts toward an HIV vaccine focus on inducing broadly neutralizing antibodies, but eliciting both neutralizing antibodies (nAbs) and cellular responses may be superior. Here, we immunized macaques with an...